Attorney and Author, U.S. of Opioids
Harry Nelson has been called America’s #1 healthcare lawyer. He is a leading expert on healthcare and life science legal issues. Harry is passionate about making sense of complex topics and navigating the way forward for healthcare organizations, government, employers, investors, and the public.
For over two decades, he has been a leading problem-solver for the healthcare industry, focused on regulatory and reimbursement challenges and strategy, including fraud and abuse, corporate practice of medicine issues, clinical safety, and data security. Harry has been at the forefront of many next generation businesss models and technologies, working with industry, investors, government regulators, and payors to pave the way innovation. His areas of expertise include:
-Behavioral Health (Addiction (SUD) Treatment, Eating Disorders, Mental Health, Autism)
-Telehealth / Digital Health Technology Ventures
-Direct-to-Consumer Health Ventures
-Future of U.S. Healthcare (Healthcare Reform, Clinical Integration and Value-Based Care, Medicare and Medicaid, Workplace Wellness)
-Innovative Physician Organizational Models (Concierge Medicine, Retail Clinics, and Telehealth)
-FDA Biologic Products (HCT/Ps, Stem Cell therapeutics, Section 361 Pathway)
-Cannabis and Psychedelics
-Medicare, Medicaid, and Insurance Reimbursement
-Health Facility Licensing
Harry writes and speaks frequently about the future of U.S. healthcare for numerous publications. His April 2019 book, The United States of Opioids: A Prescription for Liberating a Nation in Pain (Forbes) has been bestseller and has been hailed as a leading text focusing on understanding the crisis comprehensively and finding solutions to reduce overdoses, expand access to addiction treatment and mental health, and address underlying drivers. The books shares lessons of Harry’s deep dive into opioid crisis response, which led to his being an expert on the crisis response and organizational turnarounds after rashes of overdoses and suicides in addiction treatment programs. His 2017 book, From ObamaCare to TrumpCare: Why You Should Care has also been praised for its an analysis of the future of U.S. healthcare.
He sits on the boards of several healthcare organizations and is consulted regularly by federal and state executive agencies, legislators, and policymakers. He chairs the board of the Behavioral Health Association of Providers, an organization that develops standards to improve the quality and safety of behavioral health. He also testifies regularly as an expert witness.